Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Osmotica Pharmaceuticals Plc (OSMT)

Osmotica Pharmaceuticals Plc (OSMT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 346,736
  • Shares Outstanding, K 51,521
  • Annual Sales, $ 263,700 K
  • Annual Income, $ -109,400 K
  • 60-Month Beta N/A
  • Price/Sales 1.27
  • Price/Cash Flow 2.06
  • Price/Book 2.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.68 +109.50%
on 11/13/19
7.97 -3.39%
on 12/10/19
+3.70 (+92.50%)
since 11/08/19
3-Month
3.07 +150.81%
on 09/11/19
7.97 -3.39%
on 12/10/19
+4.50 (+140.63%)
since 09/10/19
52-Week
2.20 +250.00%
on 05/23/19
9.35 -17.65%
on 01/16/19
-0.15 (-1.91%)
since 12/10/18

Most Recent Stories

More News
Is OSMOTICA PHARM (OSMT) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

OSMT : 7.70 (+14.41%)
OSMT vs. QGEN: Which Stock Should Value Investors Buy Now?

OSMT vs. QGEN: Which Stock Is the Better Value Option?

OSMT : 7.70 (+14.41%)
QGEN : 41.68 (+0.39%)
Moving Average Crossover Alert: Osmotica Pharmaceuticals

Osmotica Pharmaceuticals is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

OSMT : 7.70 (+14.41%)
Buy These 6 Best Value Stocks to Make the Most of P/B Ratio

P/B ratio is emerging as a convenient tool for identifying low-priced stocks with high-growth prospects.

CYOU : 9.69 (-0.72%)
PWR : 39.91 (-1.43%)
SNX : 125.84 (+0.18%)
NAVI : 13.81 (+0.15%)
OSMT : 7.70 (+14.41%)
DBI : 14.23 (-16.29%)
The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical

BDSI : 6.45 (+0.94%)
IRWD : 12.45 (+0.97%)
SEM : 22.94 (+0.17%)
JNCE : 8.40 (+3.26%)
OSMT : 7.70 (+14.41%)
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

Healthcare bounced back with an outperformance starting the fourth quarter.

CNCR : 23.26 (+0.23%)
SBIO : 42.46 (+1.41%)
IHF : 193.62 (-0.15%)
BBC : 36.01 (+2.36%)
IRWD : 12.45 (+0.97%)
SEM : 22.94 (+0.17%)
OSMT : 7.70 (+14.41%)
JNCE : 8.40 (+3.26%)
GNOM : 16.09 (+1.36%)
Is OSMOTICA PHARM (OSMT) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

OSMT : 7.70 (+14.41%)
OSMT or QGEN: Which Is the Better Value Stock Right Now?

OSMT vs. QGEN: Which Stock Is the Better Value Option?

OSMT : 7.70 (+14.41%)
QGEN : 41.68 (+0.39%)
Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)

Vertical Pharmaceuticals, LLC (a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) ("Osmotica" or the "Company"), a fully integrated biopharmaceutical company) today announced that the Company...

OSMT : 7.70 (+14.41%)
Osmotica Pharmaceuticals plc Reports Third Quarter 2019 Results

Third quarter 2019 total revenue of $65.5 million

OSMT : 7.70 (+14.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade OSMT with:

Business Summary

Osmotica Pharmaceuticals Public Limited Company operates as a biopharmaceutical company. It offers tablets, dietary supplements and drugs for the treatment of women's health. The company's product pipeline consists of Methylphenidate HCl ER 72 mg Tablets, Osmolex ER(TM), Lorzone(R), ConZip(R), Divigel(R)...

See More

Key Turning Points

2nd Resistance Point 8.72
1st Resistance Point 8.21
Last Price 7.70
1st Support Level 6.95
2nd Support Level 6.20

See More

52-Week High 9.35
Last Price 7.70
Fibonacci 61.8% 6.62
Fibonacci 50% 5.78
Fibonacci 38.2% 4.93
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar